Lisa R. Diller
Professor
Pediatric Cancer
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for more than 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.
Research Interest
Pediatric Cancer
Publications
-
Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS et al (2009) Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 14 :2339-55.
-
Diller L (2011) Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia. N Engl J Med 15 :1417-1424.
-
Foulkes WD, Kamihara J, Evans DGR, Brugières L, Bourdeaut F et al (2017) Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Clin Cancer Res12 :62-67.
